Virica Biotech
PrivateLast Round
Grant
Dec 2, 2024
Total Funding Raised
$8.73M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Virica Biotech is a biotechnology company that develops Viral Sensitizer (VSE™) technology to improve the manufacturing productivity and cost-efficiency of viral medicines, including cell and gene therapies and vaccines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Virica Biotech Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Virica Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 2, 2024 | ||||
| Debt | Jun 24, 2024 | ||||
| Grant | Jan 26, 2024 | ||||
| Grant | Nov 1, 2023 | ||||
| Grant | Apr 21, 2023 | ||||
Grant | May 2, 2022 |
Key People
Founding team and executive leadership
Virica Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dynamk Capital | Series A |
| Federal Economic Development Agency for Southern Ontario | Debt |
| Ontario Together Fund | Grant |
| National Research Council Canada Industrial Research Assistance Program | Grant |
| Innovate UK | Grant |
| Innovation, Science and Economic Development Canada | Grant |
| AyaWas Group | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Launched Viric.AI, an active learning platform for biomanufacturing.
- Apr 16, 2026
Monthly visitors grew 57% MoM, reaching 2.5K.
Virica Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Virica Biotech's valuation, stock price, and market status.